2008 Barcelona - European Society of Human Genetics

Keyword Index
PND: EPL3.2
podocin gene (NPHS2): P05.028
podocin: P05.145, P07.098
POF: P01.091, P05.160
point mutations: P01.230, P07.049
Poland syndrome (PS): C11.4
policy: P09.07, P09.51
polimorfisms: P06.304
Poly (A) binding protein nuclear 1: P01.217
Poly T: P07.083
polycystic kidney disease: P03.58
Polycythemia vera: P04.118
polydactyly: P01.131, P01.143, P02.149
polygenic: S06.1
polyglutamine: P05.175
polymicrogyria: P02.033
polymorphic loci: P06.162
polymorphic variation: P02.178
polymorphism of serotonin transporter gene:
P07.100
polymorphism of STR loci: P07.101
polymorphism: P01.067, P02.181, P04.047,
P04.203, P06.002, P06.036, P06.052,
P06.072, P06.075, P06.081, P06.088,
P06.095, P06.134, P06.142, P06.145,
P06.147, P06.166, P06.171, P06.174,
P06.222, P06.235, P06.237, P06.256,
P06.279, P06.286, P06.291, P06.310,
P06.312, P07.025, P07.032, P07.034,
P07.054, P07.077, P07.099, P07.133, P08.83
polymorphisms: P01.041, P04.138, P06.213,
P06.320, P07.020, P07.065, P07.086,
P07.102
Polyploidy: P03.59
PON polymorphism: P02.241
PON: P06.236
PON1: P06.237
poor prognosis: P04.167
population carrier screening: EPL4.5
population differences: P07.103
population frequencies of CFTR mutations:
P07.103
population genetic diversity: P07.103
population genetics: P07.117
population genomics: P09.51
population screening: P07.131
population: P01.054, P06.239
population-based study: P06.157
populations: P07.034, P07.120
porphobilinogen deaminase: P05.161
Portugal: P10.16
portuguese founder mutation: P04.044
portuguese screening: P04.042
Postnatal cytogenetics: P02.022
postnatal: P01.158
potential years of life lost: P09.52
POU3F4: P01.277
power performance: P06.129
PPAR-alpha: P07.104
PPARG: P06.238
Practice: EP05.2
Prader Willi Syndrome: P08.63
Prader-Willi Syndrome (PWS): P03.70
Prader-Willi syndrome: P02.056, P02.058
preaxial polydactyly II: P01.149
preconception carrier screening: EP06.3
preconception screening: EP14.20
preconceptional carrier screening: EP01.08
predictive test: EP08.6
predictive testing: EP08.2, P09.32
predictive value: P01.319
predictive: EP08.5
preeclampsia: P06.239
pregnant: EP01.10
preimplantation genetic diagnosis and
screening: P01.347
preimplantation genetic diagnosis: C09.3,
C09.5, EPL3.1, P03.26, P03.27
preimplantation genetic screening: C09.6,
P03.12
preleukaemic clone: P04.095
Premature Chromosome Condensation:
P02.163
Premature Ovarian Failure: P05.162,
P06.240
premature stop codon: P01.119
Premutation and intermediate alleles:
P01.248
premutation carrier: P01.092, P01.098
prenatal counselling: P09.53
prenatal diagnosis,: P01.252
Prenatal diagnosis: C09.1, EP14.21,
P01.012, P01.025, P01.026, P01.122,
P01.151, P01.192, P01.207, P01.208,
P01.209, P02.088, P02.155, P02.190,
P02.212, P03.03, P03.05, P03.13, P03.16,
P03.37, P03.40, P03.44, P03.55, P03.57,
P03.59, P03.60, P03.61, P03.65, P03.76,
P09.04, P09.24, P09.26
prenatal genetic counselling: P03.67
prenatal genetics: P09.13
Prenatal image: P01.182
prenatal screening: C09.2, EP01.09, P09.54
prenatal testing: EP10.01, EPL4.2, EPL4.4,
P03.34
prenatal: P01.157, P02.181, P03.04, P03.75
Presenil dementia: P01.351
presenilin: P01.242
Prestige: P02.182
presymptomatic testing: EP08.7
preterm delivery: P03.33
prevalence rates of hereditary disorders:
P01.002
prevalence: P07.107
prevention: EP10.11, P01.023, P03.27,
P09.24
preventive behaviour: EPL1.5
primary congenital glaucoma: P06.241,
P07.105
Primary Hyperoxaluria: P01.348
Primary Lateral Sclerosis: P06.242
primary lymphoedema: P01.173
primary microcephaly: P05.121
primary ovarian failure: P02.183
primer design: P08.67
Prion: PL4.1
PRKAA2: P06.268
PRKCA: P06.193
process: EP10.12
professional education: P09.09
professional ethics: EPL2.4
professional training course: P09.55
progeroid: P01.349
promoter methylation: P04.205
promoter mutations: P05.017
Promoter: P05.046, P05.071, P08.08, P08.43
propionic acidemia: P01.048
proprioceptive training: P10.10
ProSeeK: P08.64
prosopagnosia: P07.106
prostate cancer: C10.1, EP02.1, EP11.2,
P04.154, P04.181, P04.182, P04.183,
P04.184, P04.185, P04.186, P04.187,
P04.188, P04.203
protection: P09.66
protein glycosylation: P01.273
protein misfolding: S09.3
protein regulation: P03.29
proteinuria: P05.059
proteomics: P02.234
proteus syndrome: P01.350
prothrombin: P09.61
ps2 gene: P05.004
PSAGN: P06.167
PSEN 1 deletion: P01.351
pseudo-Angelman phenotype: P02.164
Pseudohypoparathyroidism: P05.163
pseudoisodicentric chromosome 18: P03.66
Pseudoxanthoma elasticum: C06.5, P05.164
psoriasis: P06.243, P06.244, P06.317, S01.3
PSORS6: P06.092
psychiatric genetics: EPL2.3
Psychological distress: EP12.1
psychological features: EP14.16
psychological impact: EP08.7, EP08.8,
EP10.20, EP14.18
psychological stress: P07.061
psychological support: EP14.21
Psychosis: P06.246
Psychosocial impacts: EP14.08
Psychosocial support: EP13.9
psychosocial: EP13.7, EPL6.3
PTCH: P06.118
PTCH1 gene: P04.189
PTCH1: P04.150
PTEN: P04.012, P04.190, P04.191
PTPN11/SHP2: P01.188
PTPN11: P01.180, P01.186, P01.187
PTPN22: P06.247
public engagement: EPL2.3
Public Health: S03.4
public opinion: C14.5
public policy: P09.33
public understanding: EP06.2
pulmonary arterial hypertension: P09.56
pulmonary disease: P01.333
pulmonary vein stenosis: P01.352
pure partial monosomy 13q: P02.082
pure: P02.046
PVRL1: P06.248
PWS: P02.059
PXE: P05.164